2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoreliability
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee
Reviewers

Partnering Events:

TechConnect Summit
Clean Technology 2008
Steven Xanthoudakis

Steven Xanthoudakis

Director, Licensing and External Research
Merck Research Labs, Canada

Dr. Steven Xanthoudakis earned his doctoral degree from the Department of Microbiology and Immunology at McGill University in 1990. Following his post-doctoral training with Dr. Tom Curran at the Roche Institute of Molecular Biology in New Jersey, he assumed a faculty position as a Research Investigator in the Department of Neurogenetics at Hoffman La Roche. He was recruited back to Montreal in 1996 to join Merck Frosst Canada as a Senior Research Scientist where he focused on advancing several early stage drug discovery programs in the neuroscience, respiratory and cardiovascular areas. Since early 2007 he has been involved in coordinating Merck and Co’s Canadian R & D out-reach program. In his current position as Director, Licensing and External Research for Merck Research Laboratories, his primary role is to build lasting relationships with both the biotechnology and academic research communities and to help foster partnering opportunities which fit with Merck’s strategic research and development goals across all therapeutic and technology areas. Dr. Steven Xanthoudakis is based out of the Merck Frosst Centre for Therapeutic Research in Montreal, Canada.

Speaking in the 2008 TechConnect Summit.


View Confimed Speakers

← Back to Conferences & Symposia